-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II

Acute Lymphoblastic Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Jiangyan Yu, MSc1*, Simon V. van Reijmersdal1*, Alexander Hoischen, PhD1*, Edwin Sonneveld, PhD2*, Peter M. Hoogerbrugge, MD, PhD2,3, Esmé Waanders, PhD1 and Roland P. Kuiper, PhD1

1Department of Human Genetics, Radboud university medical center, Nijmegen, Netherlands
2Dutch Childhood Oncology Group, The Hague, Netherlands
3Princess Máxima Center for Pediatric Oncology, De Bilt, Netherlands

Gabriele Escherich, MD1*, Udo zur Stadt, PhD2*, Malik Alawi3* and Martin A. Horstmann, MD4*

1University Medical Center Hamburg Eppendorf, German Cooperative Study Group for Childhood Acute Lymphoblastic Leukemia (COALL), Eppendorf, Germany
2Center for Diagnostics, University Medical Center Hamburg Eppendorf, Hamburg, Germany
3Bioinformatics Core, University Medical Center Hamburg Eppendorf, Hamburg, Germany
4Pediatric Hem., Hamburg Univ. Med. Ctr., Hamburg, Germany

Annette Fasan, PhD*, Wolfgang Kern, MD, Niroshan Nadarajah, M.Sc.*, Simone Weber*, Sonja Schindela*, Nicole Schlenther*, Susanne Schnittger, PhD, Torsten Haferlach and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

Yuko Sekiya, MD1*, Yusuke Okuno, MD, Ph.D.1*, Hideki Muramatsu, MD, PhD1, Atsushi Narita, M.D.1*, Kyogo Suzuki, MD1*, Xinan Wang, PhD1*, Nozomu Kawashima, MD1*, Yinyan Xu, PhD1*, Hirotoshi Sakaguchi, MD, PhD2*, Nao Yoshida, MD, PhD2*, Asahito Hama, MD, PhD1*, Yoshiyuki Takahashi, MD, PhD1, Koji Kato, MD, PhD2 and Seiji Kojima, MD, PhD1*

1Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

Shalini C. Reshmi, PhD1*, Eileen Stonerock, BS2*, Michael J. Borowitz, MD, PhD3, William J Geese, PhD4*, Diane Healey, MS5*, Julie M. Gastier-Foster, PhD1, Stephen P. Hunger, MD6, Andrea Biondi, Prof, MD7 and Giovanni Cazzaniga8

1The Ohio State University, Nationwide Children's Hospital, Columbus, OH
2Nationwide Children’s Hospital, Columbus, OH
3Hematologic Pathology, Johns Hopkins University, Baltimore, MD
4Bristol-Myers Squibb, Princeton, NJ
5Research and Development/Global Clinical Research Oncology, Bristol-Myers Squibb, Wallingford, CT
6Children's Hospital Philadelphia, Philadelphia, PA
7Centro Ricerca Tettamanti, Clinica Pediatrica, Universitŕ Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy
8Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy

Marian H. Harris, MD, PhD1*, Traci M. Blonquist, MS2*, Uma H. Athale, M.D., M.Sc.3, Luis A. Clavell, MD4, Peter D. Cole, MD5, Kara M. Kelly, MD6, Caroline Laverdiere, MD7, Jean-Marie Leclerc, MD7, Bruno Michon, MD, FRCPC8*, Marshall A. Schorin, MD9, Jennifer J.G. Welch, MD10, Donna S. Neuberg, Sc.D.2, Stephen E. Sallan, MD11,12 and Lewis B. Silverman, MD11,13

1Department of Pathology, Boston Children's Hospital, Boston, MA
2Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
3Division of Hematology/Oncology, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada
4San Jorge Children's Hospital, San Juan, PR
5Pediatrics, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
6Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York, NY
7Hematology-Oncology Division, Charles Bruneau Cancer Center, Sainte-Justine University Hospital, University of Montreal, Montreal, QC, Canada
8Centre Hospitalier Universitaire de Quebec, Sainte-Foy, QC, Canada
9Inova Fairfax Hospital for Children, Falls Church, VA
10Pediatric Hematology Oncology, Hasbro Children's Hospital/Brown University, Providence, RI
11Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA
12Division of Pediatric Hematology-Oncology, Boston Children's Hospital, Boston, MA
13Division of Pediatric Hematology, Boston Children's Hospital, Boston, MA

Mary Sartor, PhD1*, Draga Barbaric, MBBS2,3,4*, Tamara Law, BSc (Hons)5*, DR Anuruddhika Dissanayake, PhD6*, Nicola C Venn5*, Mawar Karsa, BSc (Hons), MSc6*, Sue W J Wong, BSc, MSc(med)1*, Murray D Norris, PhD6,7*, Tamas Revesz, MD, PhD8,9*, Petra Ritchie, MBBS8*, Peter J Shaw10, Kenneth F Bradstock, MBBS PhD FRACP FRCPA11, Luciano Dalla Pozza, MBBS, FRACP12,13*, Toby N Trahair, PhD, MBBS3,6,14,15* and Rosemary Sutton, PhD4,13,16*

1Flow Cytometry Unit, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, Australia
2Kids Cancer Centre, Sydney Children’s Hospital, Randwick, Australia
3Australian and New Zealand Children’s Haematology/Oncology Group, Melbourne, Australia
4School of Women’s and Children’s Health,, University of New South Wales, Sydney, Australia
5Molecular Diagnostics, Children's Cancer Institute Australia, Sydney, Australia
6Molecular Diagnostics, Children's Cancer Institute, Sydney, Australia
7Centre for Childhood Cancer Research, University of New South Wales, Sydney, Australia
8SA Pathology, Women and Children’s Hospital, Adelaide, Australia
9Faculty of Health Science, University of Adelaide, Adelaide, Australia
10Bone Marrow Transplant Services, Sydney Children’s Hospital Network, Westmead, Sydney, Australia
11Haematology, Westmead Hospital, Westmead, Australia
12Sydney Children's Hospital Network, Sydney, Australia
13Australian and New Zealand Children's Haematology/Oncology Group, Melbourne, Australia
14Kids Cancer Centre, Sydney Children’s Hospital Network, Randwick, Australia
15School of Women’s and Children’s Health,, University of NSW, Sydney, Australia
16Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia

Nikhil Patkar, MD1*, Papagudi Ganesan Subramanian, MD1*, Prashant Tembhare, MD,1*, Pratibha Amare Kadam, PhD2*, Asma Bibi, MD,1*, Karishma Chopra, MSc1*, Satish Mirgal, MSc1*, Sagar Rambhiya, MSc1*, Swapnali Joshi, MSc1*, Shruti Chaudhary, PhD1*, Russel Mascrenhas, MSc1*, Sona Dusseja, MSc1*, Gaurav Narula, MD,3*, Brijesh Arora, DM3*, Shripad Banavali, MD3* and Sumeet Gujral, MD4

1Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India
2Cytogenetics Department,, Tata Memorial Centre, Mumbai, India
3Department of Medical & Pediatric Oncology, Tata Memorial Centre, Mumbai, India
4Department of Pathology, Tata Memorial Centre, Mumbai, India

Kara L. Davis, DO1, Jolanda Sarno2*, Andrea Biondi, Prof, MD3, Astraea Jager, BS4*, Giuseppe Gaipa, PhD5, Zinaida Good6* and Garry P. Nolan, Prof, PhD4*

1Pediatrics, Stanford University, Palo Alto, CA
2Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
3Centro Ricerca Tettamanti, Clinica Pediatrica, Universitŕ Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy
4Department of Microbiology and Immunology, Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Palo Alto, CA
5Department of Pediatrics, Tettamanti Research Center, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
6Stanford University, Stanford, CA

Benjamin Kobitzsch1*, Nicola Gökbuget, MD2, Stefan Schwartz, MD1*, Richard Reinhardt, PhD3*, Monika Brueggemann4*, Andreas Viardot, MD5*, Ralph Wäsch, MD, PhD6*, Michael Starck, MD7*, Eckhard Thiel, MD1, Dieter Hoelzer, MD2 and Thomas Burmeister, MD1*

1Hematology, Oncology and Tumor Immunology, Charité, Berlin, Germany
2Dept. of Medicine II, Hematology/Oncology, Goethe University, Frankfurt / Main, Germany
3Max Planck Genome Center Cologne, Cologne, Germany
4Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany
5Med. Dept. III (Hematology, Oncology), Ulm University, Ulm, Germany
6Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
7Dept. of Hematology, Klinikum München-Schwabing, Munich, Germany

Kathryn G. Roberts1, Debbie Payne-Turner, BS1*, Kelly McCastlain1*, Zhaohui Gu, PhD1*, Ilaria Iacobucci, PhD1*, Richard C. Harvey2, I-Ming Chen2, Marcus Valentine3*, Deqing Pei4*, Yongjin Li, PhD5*, Jinghui Zhang, PhD5*, Cheng Cheng, Ph.D4*, Alessandro Rambaldi, MD6, Orietta Spinelli, PhD7*, Jerald P. Radich8, Mark D. Minden, MD, PhD9, Anthony V Moorman, PhD10, Bella Patel, MBBS11*, Adele K. Fielding, MB BS, PhD12, Jacob M. Rowe, MD13, Selina Luger, MD14, Jessica Kohlschmidt, PhD, BS, MS15, Krzysztof Mrózek, MD, PhD15, Guido Marcucci, MD16, Clara D. Bloomfield, MD15, Wendy Stock, MD17, Hagop M. Kantarjian, MD18, Marina Konopleva, MD, PhD18, Elisabeth Paietta, PhD19, Cheryl L Willman2 and Charles G. Mullighan1

1Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
2University of New Mexico Cancer Center, Albuquerque, NM
3Cytogenetics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN
4Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
5Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN
6Department of Hematology, Hospital Papa Giovanni XXIII, Bergamo, Italy
7Hematology and Bone Marrow Transplant Unit, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
8Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
9Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
10Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
11Queen Mary University of London, London, United Kingdom
12Department of Hematology, UCL Cancer Institute, London, United Kingdom
13Hematology, Shaare Zedek Medical Center, Jerusalem, Israel
14Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
15Comprehensive Cancer Center, The Ohio State University, Columbus, OH
16City of Hope, Duarte, CA
17University of Chicago Medical Center, Chicago, IL
18Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
19Cancer Center, Montefiore Medical Center North Division, Bronx, NY

Katherine Dormon, MSci1*, Elda S Latif, PhD2*, Matthew Bashton, PhD1*, Deepali Pal, PhD1*, Matthew Selby, MSci1*, Helen Blair, PhD1*, Vikki Rand, PhD1*, Andrew G Hall, PhD1, Josef Vormoor, MD, FRCPCH1 and Olaf Heidenreich, PhD1*

1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom
2National University of Maylasia, Bangi, Malaysia

Prashant Deshpande, MD*, Punit Jain, DM*, Ansu Abu Alex Sr., MSc*, Anu Korula, MD, DM*, Kavitha M Lakshmi, MSc*, Nisham P N, DM*, Fouzia NA, DM*, Aby Abraham, MD, DM*, Alok Srivastava, MD, Poonkuzhali Balasubramanian, M.Sc., Ph.D, Biju George, DM and Vikram Mathews, DM

Department of Haematology, Christian Medical College, Vellore, India

Alyssa I. Clay, BS1*, Theresa Hahn, PhD2, Leah Preus, MS1*, Kenan Onel, MD, PhD3, Qianqian Zhu, PhD4*, Christopher Haiman, ScD5*, Daniel O. Stram, PhD5*, Loreall C. Pooler, MS5*, Xin Sheng, MS5*, Daniel Weisdorf, MD6, Li Yan, PhD4*, Qian Liu, MA7*, Qiang Hu, MD, PhD4*, Song Liu, PhD4*, Sebastiano Battaglia, PhD8*, Xiaochun Zhu, MS9*, AnneMarie W. Block, PhD10, Sheila Sait, PhD10*, Christine B. Ambrosone, PhD1*, David Tritchler, ScD7,11*, Stephen R. Spellman, MBS12*, Marcelo C. Pasquini, MD13, Philip L. McCarthy, MD2 and Lara E. Sucheston-Campbell, PhD1*

1Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY
2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
3The University of Chicago, Comer Children's Hospital, Chicago, IL
4Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY
5Preventive Medicine, University of Southern California, Los Angeles, CA
6Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
7Biostatistics, State University of New York at Buffalo, Buffalo, NY
8Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY
9Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
10Clinical Cytogenetics Laboratory, Roswell Park Cancer Institute, Buffalo, NY
11Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
12CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match®, Minneapolis, MN
13Medicine, Medical College of Wisconsin, Milwaukee, WI

Valeria Cazzaniga, PhD1,2*, Paola De Lorenzo3*, Federica Mottadelli2*, Grazia Fazio, PhD2*, Tiziana Villa2*, Vincenzo Rossi2*, Martina Pigazzi, PhD4*, Marcela B. Mansur, PhD1*, Marco Zecca, MD5*, Elena Barisone, MD6*, Franco Locatelli, MD7, Giuseppe Basso, Prof, MD4, Maria Grazia Valsecchi, PhD3, Mel Greaves, FRS1, Andrea Biondi, Prof, MD8, Anthony M Ford1 and Giovanni Cazzaniga2

1Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
2Centro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM/San Gerardo Hospital, Monza, Italy
3EsPhALL Trial Data Center, University of Milano-Bicocca, Monza, Italy
4Woman and Child Health Department, University of Padova, Padova, Italy
5Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
6Pediatric Hemato-Oncology, Ospedale Infantile Regina Margherita, Turin, Italy
7Department of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesů, Rome, Italy
8Centro Ricerca Tettamanti, Clinica Pediatrica, Universitŕ Milano Bicocca, Osp. San Gerardo/Fondazione MBBM, Monza (MB), Italy

Anna Ferrari, PhD1*, Andrea Ghelli Luserna Di Rora2*, Italo Do Valle3,4*, Marianna Garonzi5*, Valentina Robustelli2*, Jesus Maria Hernandez-Rivas, PhD6*, Alessandra Santoro7*, Sarka Pospisilova, Prof.8*, Torsten Haferlach9, Antonella Padella1*, Giorgia Simonetti, PhD1*, Cristina Papayannidis, MD, PhD10, Maria Chiara Abbenante, MD1*, Marco Sazzini11*, Alberto Ferrarini, PhD5*, Julien Schira12*, Massimo Delledonne, PhD13*, Gastone Castellani3*, Daniel Remondini, PhD3* and Giovanni Martinelli, MD, PhD10

1University of Bologna, Bologna, Italy
2DIMES, Department of Hematology and Medical Sciences “L. and A. Serŕgnoli”, Bologna, Italy, Bologna, Italy
3Department of Physics and Astronomy, University of Bologna, Bologna, Italy
4CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil
5Department of Biotechnology, University of Verona, Verona, Italy
6Hematology, Salamanca Universitary Hospital, Salamanca, Spain
7Divisione di Ematologia con UTMO, A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
8Department of Internal Medicine - Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
9MLL Munich Leukemia Laboratory, Munich, Germany
10Bologna University School of Medicine, Bologna, Italy
11Department of Biological, Geological and Environmental Sciences, University of Bologna, Bologna, Italy
12FASTERIS, Geneve, Switzerland
13Personal Genomics, Verona, Italy

Dino Mašić, MRes*, Amir Enshaei, PhD*, Lisa Jones, BSc*, Christine Harrison, PhD FRCPath FMedSci and Lisa Jane Russell, PhD*

Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom

Lorenz Bastian1,2*, Martin Neumann, MD1,2*, Nicola Gökbuget, MD3, Cornelia Schlee1*, Jutta Ortiz Tanchez1*, Sebastian Vosberg, MSc4,5,6*, Alva Rani James1,2,7*, Michael P Schroeder1*, Stefan Schwartz, MD8*, Dieter Hoelzer9, Alexander Graf, PhD6*, Stefan Krebs, PhD6*, Helmut Blum, PhD6*, Jochen Hecht10,11*, Monika Brüggemann12*, Philipp A. Greif7,13,14* and Claudia D. Baldus, MD, PhD2,15*

1Department of Hematology and Oncology, Charité University Hospital, Berlin, Germany
2German Cancer Consortium (DKTK), Berlin, Germany
3Dept. of Medicine II, Hematology/Oncology, Goethe University, Frankfurt / Main, Germany
4German Cancer Consortium (DKTK), Heidelberg, Germany
5Department of Internal Medicine III, Ludwig-Maximilians-University, Munich, Germany
6Laboratory for Functional Genome Analysis, Gene-Center, Ludwig-Maximilians-University, Munich, Germany
7German Cancer Research Center (DKFZ), Heidelberg, Germany
8Hematology, Oncology and Tumor Immunology, Charité, Berlin, Germany
9Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt / Main, Germany
10Centre for Genomic Regulation, Barcelona, Spain
11Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité-Universitätsmedizin, Berlin, Germany
12Department of Hematology and Oncology, University Hospital Kiel, Kiel, Germany
13Department of Internal Medicine 3, Ludwig-Maximilians-University, Munich, Germany
14German Cancer Consortium (DKTK), Munich, Germany
15Charité University Hospital, Berlin, Germany

Brenton G. Mar, MD, PhD1, Josephine Kahn, MD, MSc2*, Rebecca L Zon, BA2, Peter V Grauman, BS2*, Kevin Boettger, BS2*, Scott Haihua Chu, PhD3*, Scott A. Armstrong, MD, PhD4 and Benjamin L. Ebert, MD5

1Dana-Farber Cancer Institute, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Memorial Sloan Kettering Cancer Cancer, New York, NY
4Memorial Sloan-Kettering Cancer Center, New York, NY
5Division of Hematology, Brigham and Women's Hospital, Boston, MA

Hui Li, phd1*, Benshang Li1*, Fan Yang2*, Caiwen Duan2*, Yun Bai3*, Jun J Yang, PhD4, Jing Chen, MD, PhD5*, Arend von Stackelberg, MD6, Hongzhuan Chen, PhD7*, JingYan Tang, MD8, Adolfo A. Ferrando, MD, PhD9, Jinghui Zhang, PhD10*, Shengyue Wang11*, Renate Kirschner-Schwabe, PhD12* and Bin-Bing S. Zhou, PhD1*

1Department of Hematology & Oncology, Shanghai Children’s Medical Center, shanghai, China
2Key Laboratory of Pediatric Hematology & Oncology Ministry of Health,Department of Hematology & Oncology, Shanghai Children’s Medical Center, shanghai, China
3Shanghai-MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai, China., shanghai, China
4Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
5Division of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai, P.R. China, Shanghai, China
6Pediatric oncology, Charite Universitaetsmedizin Berlin, Berlin, Germany
7Department of Pharmacology, School of Basic Medicine and Collaborative Innovation Center for Translational Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China., shanghai, China
8Key Laboratory of Pediatric Hematology & Oncology Ministry of Health,Department.of Hematology and Oncology, Shanghai Children's Medical Center, Shanghai, P.R. China, Shanghai, China
9Institute for Cancer Genetics, Columbia University, New York, NY
10Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN
11Pediatric Translational Medicine Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China
12Universitätsmedizin Charité, Berlin, Germany

Masafumi Seki, MD1*, Kenichi Yoshida, MD, Ph.D.2*, Yuichi Shiraishi, MD, Ph.D.3*, Kenichi Chiba, BA3*, Hiroko Tanaka, BA3*, Motohiro Kato, MD, PhD4, Shunsuke Kimura, MD5*, Ryoji Hanada, MD6*, Katsuyoshi Koh, MD7*, Satoru Miyano, MD, Ph.D.3*, Toshihiko Imamura, MD, PhD8, Keizo Horibe, MD, PhD9, Nobutaka Kiyokawa, MD, PhD10*, Atsushi Manabe, MD, PhD5, Akira Ohara, MD, PhD11, Yasuhide Hayashi, MD, PhD12,13, Akira Oka, MD, PhD1*, Seishi Ogawa, MD, Ph.D.2 and Junko Takita, MD, PhD14*

1Department of Pediatrics, The University of Tokyo, Tokyo, Japan
2Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Department of Pediatrics, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
5Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan
6Department of Hematology/Oncology, Seriatim Children's Medical Hospital, Saitama, Japan
7Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama, Japan
8Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan
9Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
10Department of Pediatric Hematology and Oncology Research, National Research Institute For Child Health and Development, Tokyo, Japan
11Department of Pediatrics, Toho University School of Medicine, Tokyo, Japan
12Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
13Japanese Red Cross Gunma Blood Center, Maebashi, Japan
14Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Laurens T Van Der Meer, PhD1*, Jiangyan Yu, MSc2*, Miriam Butler, MSc1*, Jolien M R van der Meer, MSc1*, Roland P Kuiper, PhD2 and Frank N van Leeuwen, PhD1

1Laboratory of Pediatric Oncology, Radboud university medical center, Nijmegen, Netherlands
2Department of Human Genetics, Radboud university medical center, Nijmegen, Netherlands

Ebinger Sarah, M. Sc.1*, Özdemir Erbey, M. Sc.1*, Sebastian Tiedt, PhD1*, Christoph Ziegenhain, M. Sc.2*, Catarina Castro Alves, PhD1*, Wolfgang Enard, Prof. Dr. rer. nat.2* and Irmela Jeremias, MD1,3,4*

1Research Unit Gene Vectors, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany
2Anthropology and Human Genetics, Department Biology II, Faculty of Biology, Ludwig-Maximilians-Universität München, Munich, Germany
3Department of Oncology, Dr. von Haunersches Kinderspital, Ludwig Maximilians University, Munich, Germany
4German Cancer Research Center (DKFZ), Heidelberg, Germany

Felix Seyfried*, Salih Demir, MSc*, Klaus-Michael Debatin, MD PhD and Lueder Hinrich Meyer, MD*

Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany

Michela Carlet, PhD1*, Jenny Vergalli, M.Sc.1*, Cornelia Finkenzeller, M.Sc.1*, Michaela Grunert, PhD1* and Irmela Jeremias, MD1,2,3*

1Research Unit Gene Vectors, Helmholtz Center Munich, German Research Center for Environmental Health, Munich, Germany
2German Consortium for Translational Cancer Research (DKTK) and German Cancer Research Center (DKFZ), Munich, Germany
3Department of Oncology, Dr. von Haunersches Kinderspital, Ludwig Maximilians University, Munich, Germany

Olivia L Francis, BS, PhD1, Terry-Ann MIlford, BS1*, Ineavely Baez, BS1*, Jacqueline Coats, BS1*, Christopher L. Morris, MD, PhD1, Ross Fisher, MD,1*, Benjamin Joseph Van Handel, BS, PhD2*, Ruijun Su, MD, PhD1, Batul T. Suterwala, MD1*, Shadi Farzingohar, MD1*, Sinisa Dovat, M.D., Ph.D.3 and Kimberly Payne, PhD1

1Loma Linda University, Loma Linda, CA
2Novogenix Labs, Los Angeles, CA
3Department of Pediatrics, Pennsylvania State University College of Medicine, Hershey, PA

Vera Muench1,2*, Luca Trentin, PhD1*, Julia Herzig1*, Johann Krauss3*, Hans A Kestler3,4*, Geertruy te Kronnie5*, Klaus-Michael Debatin, MD PhD6 and Lueder Hinrich Meyer, MD6*

1Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany
2International Graduate School of Molecular Medicine, Ulm University, Ulm, Germany
3Ulm University, Ulm, Germany
4Fritz Lipmann Institute, Jena, Germany
5University of Padua, Padova, Italy
6Department of Pediatrics and Adolescent Medicine, Ulm University Medical Center, Ulm, Germany

*signifies non-member of ASH